TargetMol

Iniparib

Product Code:
 
TAR-T6224
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6224-5mg5mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-10mg10mg£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-25mg25mg£173.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-50mg50mg£264.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-100mg100mg£374.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-200mg200mg£552.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6224-500mg500mg£841.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Iniparib (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC).
CAS:
160003-66-7
Formula:
C7H5IN2O3
Molecular Weight:
292.032
Pathway:
Chromatin/Epigenetic; DNA Damage/DNA Repair; Microbiology/Virology
Purity:
0.9828
SMILES:
NC(=O)c1ccc(I)c(c1)[N+]([O-])=O
Target:
PARP; Influenza Virus

References

Bauer PI, et al. Biochem Pharmacol, 2002, 63(3), 455-462. Patel AG, et al. Clin Cancer Res, 2012, 18(6), 1655-1662. Liu X, et al. Clin Cancer Res, 2012, 18(2), 510-523. Yin S, et al. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS One. 2017 Aug 17;12(8):e0183578. Ma W, et al. Proc Natl Acad Sci U S A, 2012, 109(17), 6590-6595. Mendeleyev J, et al. Biochem Pharmacol, 1995, 50(5), 705-714.